Vitiligo, a common depigmenting skin disorder, has an estimated prevalence of 0.5–2% of
the population worldwide. The disease is characterized by the selective loss of melanocytes …

Vitiligo is an autoimmune depigment disease results from extensive melanocytes
destruction. The destruction of melanocyte is thought to be of multifactorial causation …

When immunologic tolerance to auto-reactive immune cells is lost, autoimmune illness
manifests as the immune system attacking self-molecules. Numerous autoimmune diseases …

Vitiligo is the most common depigmenting disorder affecting 0.1%–2% of the population
worldwide. The characteristic white patches result from the selective loss of melanocytes …

Vitiligo is an autoimmune disease of the skin that targets pigment-producing melanocytes
and results in patches of depigmentation that are visible as white spots. Recent research …

Vitiligo is an autoimmune disease in which depigmented skin results from the destruction of
melanocytes, with epidemiological association with other autoimmune diseases. In previous …

Vitiligo is an acquired pigmentary disorder of unknown etiology that is clinically
characterized by the development of white macules related to the selective loss of …

Vitiligo is an acquired hypopigmentation of the skin due to a progressive selective loss of
melanocytes; it has a prevalence of 1–2% and appears as rounded, well-demarcated white …

Previous studies have estimated a prevalence of a broad grouping of autoimmune diseases
of 3.2%, based on literature review of studies published between 1965 and 1995, and 5.3 …

Objective To conduct a meta-analysis assessing the prevalence of vitiligo. Methods
Literatures that reported prevalence rates of vitiligo were identified using EMBASE, PubMed …